← Open Payments lookup

MOHAMMAD KHAN: Open Payments

NPI 1528028032 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$821 in 41 payments from 11 companies in 2025. Trend: 2023 $253 · 2024 $294 · 2025 $821

Food & beverage: $821
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$216
Takeda Pharmaceuticals U.S.A., Inc.6$131
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$103
E.R. Squibb & Sons, L.L.C.4$80
Axsome Therapeutics, Inc.3$58
Corium, LLC3$54
ABBVIE INC.3$50
Noven Therapeutics, LLC2$40
Janssen Pharmaceuticals, Inc2$37
Supernus Pharmaceuticals, Inc.2$31

Products named: REXULTI, TRINTELLIX, CAPLYTA, COBENFY, Auvelity, Azstarys, VRAYLAR, Xelstrym.

Industry payments across TX — which companies pay providers there.